Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An uncommon, aggressive malignant smooth muscle neoplasm. It is characterized by the presence of atypical large spindle or round cells, nuclear palisading, tumor cell necrosis, mitotic figures and may be associated with vascular invasion.
Biomarker and diagnostic research for conventional leiomyosarcoma has been reported in the published literature.
No clinical trials have been registered for conventional leiomyosarcoma.
19 publications have been identified in PubMed for conventional leiomyosarcoma. Research spans Case Report / Case Series (53%), Diagnostic / Biomarker (16%), and Clinical Trial Publication (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 | 53% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 6:42 AM UTC
3 |
16% |
Clinical study results | 3 | 16% |
Research summaries | 1 | 5% |
Disease patterns and progression | 1 | 5% |
New treatment approaches | 1 | 5% |
Bahall V (2026). [PMID: 42100585](https://pubmed.ncbi.nlm.nih.gov/42100585/). *Case Rep Womens Health*. [Case Report / Case Series]
Komura N (2026). [PMID: 41455452](https://pubmed.ncbi.nlm.nih.gov/41455452/). *International journal of gynecological cancer : official journal of the International Gynecological Cancer Society*. [Epidemiology / Natural History]
Hoang M (2026). [PMID: 41711635](https://pubmed.ncbi.nlm.nih.gov/41711635/). *The American Journal of dermatopathology*. [Case Report / Case Series]
Lee CH (2026). [PMID: 41424301](https://pubmed.ncbi.nlm.nih.gov/41424301/). *Histopathology*. [Diagnostic / Biomarker]
Martin-Broto J (2026). [PMID: 41559089](https://pubmed.ncbi.nlm.nih.gov/41559089/). *Nature communications*. [Clinical Trial Publication]
Feng X (2026). [PMID: 42236131](https://pubmed.ncbi.nlm.nih.gov/42236131/). *J Clin Pathol*. [Case Report / Case Series]
Qi H (2026). [PMID: 42105786](https://pubmed.ncbi.nlm.nih.gov/42105786/). *J Immunol Res*. [Review / Meta-Analysis]
Martin-Broto J (2025). [PMID: 39356980](https://pubmed.ncbi.nlm.nih.gov/39356980/). *Journal of clinical oncology : official journal of the American Society of Clinical Oncology*. [Diagnostic / Biomarker]
Tasar Kapakli E (2025). [PMID: 39892100](https://pubmed.ncbi.nlm.nih.gov/39892100/). *Annals of diagnostic pathology*. [Case Report / Case Series]
Moisan R (2025). [PMID: 40746226](https://pubmed.ncbi.nlm.nih.gov/40746226/). *Pediatric blood & cancer*. [Clinical Trial Publication]